Skip to main content

Nanocardiology

  • Chapter
  • First Online:
The Handbook of Nanomedicine
  • 2195 Accesses

Abstract

Nanocardiology is the application of nanobiotechnology to cardiovascular diseases. Recent rapid advances in nanobiotechnology offer a wealth of new opportunities for diagnosis and therapy of cardiovascular diseases (Jain 2011a). As far back as 2003, the National Heart, Lung, and Blood Institute, USA, convened a working group on nanotechnology for translational applications to heart, lung, blood disorders, and cardiovascular complications of sleep apnea to solve clinical problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ashammakhi N, Wimpenny I, Nikkola L, Yang Y. Electrospinning: methods and development of biodegradable nanofibres for drug release. J Biomed Nanotechnol 2009;5:1–19.

    Article  CAS  Google Scholar 

  • Banai S, Chorny M, Gertz SD, et al. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 2005;26:451–61.

    Article  CAS  Google Scholar 

  • Brito L, Amiji M. Nanoparticulate carriers for the treatment of coronary restenosis. Int J Nanomedicine 2007;2:143–61

    Article  CAS  Google Scholar 

  • Chan JM, Zhang L, Tongc R, et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A 2010;107:2213–8.

    Article  CAS  Google Scholar 

  • Chen HH, Josephson L, Sosnovik DE. Imaging of apoptosis in the heart with nanoparticle technology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:86–99.

    Article  CAS  Google Scholar 

  • Chnari E, Nikitczuk JS, Uhrich KE, et al. Nanoscale Anionic Macromolecules Can Inhibit Cellular Uptake of Differentially Oxidized LDL. Biomacromolecules 2006;7:597–603.

    Article  CAS  Google Scholar 

  • Davis ME, Hsieh PC, Takahashi T, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006;103:8155–60.

    Article  CAS  Google Scholar 

  • Feng SS, Zeng W, Teng Lim Y, et al. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomed 2007;2:333–44.

    Article  CAS  Google Scholar 

  • Floriano PN, Christodoulides N, Miller CS, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 2009;55:1530–8.

    Article  CAS  Google Scholar 

  • Guarise C, Pasquato L, De Filippis V, Scrimin P. Gold nanoparticles-based protease assay. Proc Natl Acad Sci U S A 2006;103:3978–82.

    Article  CAS  Google Scholar 

  • Hsieh PCH, Davis ME, Gannon J, et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006;116:237–48.

    Article  CAS  Google Scholar 

  • Jain KK. Handbook of Biomarkers. Springer, New York, 2010.

    Google Scholar 

  • Jain KK. Applications of Biotechnology in Cardiovascular Therapeutics. Springer, New York, 2011a.

    Google Scholar 

  • Kumar A, Jena PK, Behera S, et al. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 2010;6:64–9.

    Article  CAS  Google Scholar 

  • Lanza GM, Winter PM, Caruthers SD, et al. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomedicine 2006;1:321–9.

    Article  CAS  Google Scholar 

  • Leite EA, Grabe-Guimarães A, Guimarães HN, et al. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci 2007;80:1327–34.

    Article  CAS  Google Scholar 

  • Margolis J, McDonald J, Heuser R, et al. Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study. Clin Cardiol 2007;30:165–70.

    Article  Google Scholar 

  • Saraste A, Nekolla SG, Schwaiger M. Cardiovascular molecular imaging: an overview. Cardiovasc Res 2009;83:643–52.

    Article  CAS  Google Scholar 

  • Uwatoku T, Shimokawa H, Abe K, et al. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats. Circ Res 2003;92:e62–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jain, K.K. (2012). Nanocardiology. In: The Handbook of Nanomedicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-983-9_10

Download citation

Publish with us

Policies and ethics